Clinical Trial Update: Sodium Oxybate in Schizophrenia With Insomnia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of sodium oxybate in schizophrenia with insomnia; the study has completed and results were posted in February 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia in Schizophrenia
• Schizophrenia

Drugs mentioned

• Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Insomnia Related to Schizophrenia (307.42) | Phase 2 | Status: COMPLETED | Results posted: 2016-02-08